Tandem Diabetes Care Inc
-
Health News
Here’s what Wall Street is saying about obesity drug Wegovy following Novo Nordisk’s key study
[ad_1] Analysts are largely optimistic about a new class of anti-obesity medications following a landmark study released over the weekend.…
Read More » -
Health News
Obesity drugs’ popularity put a dent in these stocks. Why analysts say they’re still worth buying
[ad_1] Industry analysts are insisting that new weight loss and diabetes drugs like Ozempic won’t hurt the demand for insulin…
Read More »